Celon Pharma SA (CLNP)

Currency in PLN
23.25
0.00(0.00%)
Delayed Data·
CLNP Scorecard
Full Analysis
Net income is expected to grow this year
CLNP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.1023.90
52 wk Range
20.8532.90
Key Statistics
Bid/Ask
23.25 / 23.40
Prev. Close
23.25
Open
23.7
Day's Range
23.1-23.9
52 wk Range
20.85-32.9
Volume
13.12K
Average Volume (3m)
43.91K
1-Year Change
-9.88%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLNP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.44
Upside
+18.02%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Celon Pharma SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Celon Pharma SA Company Profile

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

Employees
567
Market
Poland

Compare CLNP to Peers and Sector

Metrics to compare
CLNP
Peers
Sector
Relationship
P/E Ratio
−28.5x−3.6x−0.5x
PEG Ratio
0.60−0.310.00
Price/Book
3.0x2.1x2.6x
Price / LTM Sales
5.8x2.4x3.3x
Upside (Analyst Target)
20.4%106.3%43.5%
Fair Value Upside
Unlock4.0%6.3%Unlock

Analyst Ratings

2 Buy
2 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 27.44
(+18.02% Upside)

Earnings

Latest Release
May 21, 2025
EPS / Forecast
-0.47 / --
Revenue / Forecast
49.30M / 47.50M
EPS Revisions
Last 90 days

CLNP Income Statement

People Also Watch

36.21
ALEP
+0.22%
206.60
SNTP
+0.29%
82.63
PKN
-0.30%
14.170
MRB
-0.21%
148.00
UNTP
-0.80%

FAQ

What Stock Exchange Does Celon Pharma Trade On?

Celon Pharma is listed and trades on the Warsaw Stock Exchange stock exchange.

What Is the Stock Symbol for Celon Pharma?

The stock symbol for Celon Pharma is "CLNP."

What Is the Celon Pharma Market Cap?

As of today, Celon Pharma market cap is 1.27B.

What Is Celon Pharma's Earnings Per Share (TTM)?

The Celon Pharma EPS (TTM) is -0.83.

When Is the Next Celon Pharma Earnings Date?

Celon Pharma will release its next earnings report on 16 Sept 2025.

From a Technical Analysis Perspective, Is CLNP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Celon Pharma Stock Split?

Celon Pharma has split 0 times.

How Many Employees Does Celon Pharma Have?

Celon Pharma has 567 employees.

What is the current trading status of Celon Pharma (CLNP)?

As of 05 Aug 2025, Celon Pharma (CLNP) is trading at a price of 23.25, with a previous close of 23.25. The stock has fluctuated within a day range of 23.10 to 23.90, while its 52-week range spans from 20.85 to 32.90.

What Is Celon Pharma (CLNP) Price Target According to Analysts?

The average 12-month price target for Celon Pharma is PLN27.44, with a high estimate of PLN34 and a low estimate of PLN16. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +18.02% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.